aitiologic Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $7.44M

  • Investors
  • 8

aitiologic General Information

Description

Developer of AI-powered precision medicine technology designed for early disease detection and targeted therapy. The company utilizes multi-omics technology to decode health at the cellular level and understand the molecular root causes of health and disease, enabling healthcare professionals to enhance non-invasive prenatal and oncology testing.

Contact Information

Website
www.aitiologic.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Karl-Farkas Gasse 18
  • Vienna, Vienna 1030
  • Austria
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Vertical(s)
Artificial Intelligence & Machine Learning, Life Sciences
Corporate Office
  • Karl-Farkas Gasse 18
  • Vienna, Vienna 1030
  • Austria

aitiologic Timeline

202420252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

aitiologic Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 15-Sep-2026 $7.44M Completed Generating Revenue
2. Seed Round 01-Oct-2024 Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2024 Completed Generating Revenue
To view aitiologic’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

aitiologic Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

aitiologic Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ananda Ventures (Germany) Venture Capital Minority
Angel (individual) Minority
Heal Capital Venture Capital Minority
AWS Corporation Minority
LANA Ventures Family Office Minority
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

aitiologic FAQs

  • When was aitiologic founded?

    aitiologic was founded in 2023.

  • Where is aitiologic headquartered?

    aitiologic is headquartered in Vienna, Austria.

  • What is the size of aitiologic?

    aitiologic has 10 total employees.

  • What industry is aitiologic in?

    aitiologic’s primary industry is Drug Discovery.

  • Is aitiologic a private or public company?

    aitiologic is a Private company.

  • What is aitiologic’s current revenue?

    The current revenue for aitiologic is .

  • How much funding has aitiologic raised over time?

    aitiologic has raised $10.2M.

  • Who are aitiologic’s investors?

    Ananda Ventures (Germany), , Heal Capital, AWS, and LANA Ventures are 5 of 8 investors who have invested in aitiologic.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process